First Time Loading...

Iterum Therapeutics PLC
NASDAQ:ITRM

Watchlist Manager
Iterum Therapeutics PLC Logo
Iterum Therapeutics PLC
NASDAQ:ITRM
Watchlist
Price: 1.67 USD 6.37% Market Closed
Updated: Apr 28, 2024

Iterum Therapeutics PLC
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Iterum Therapeutics PLC
Revenue Peer Comparison

Comparables:
PRGO
JAZZ
AVDL
G
GHRS
COPN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Iterum Therapeutics PLC
NASDAQ:ITRM
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Perrigo Company PLC
NYSE:PRGO
Revenue
$4.7B
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
2%
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Revenue
$3.8B
CAGR 3-Years
17%
CAGR 5-Years
15%
CAGR 10-Years
16%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Revenue
$28m
CAGR 3-Years
8%
CAGR 5-Years
-23%
CAGR 10-Years
21%
G
GH Research PLC
NASDAQ:GHRS
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Revenue
€96.7m
CAGR 3-Years
17%
CAGR 5-Years
8%
CAGR 10-Years
6%

See Also

What is Iterum Therapeutics PLC's Revenue?
Revenue
0 USD

Based on the financial report for Dec 31, 2023, Iterum Therapeutics PLC's Revenue amounts to 0 USD.